As leaders in Business Transformation, we often instinctively reach for that big

red cost-cutting button to eliminate any unnecessary waste. The same principle

can be applied to Generative AI, which took the world by storm in 2023. While

it undoubtedly helps save time and money, Maciej Szymaszek argues that its

impact transcends mere monetary value. Leading tests, implementations,

and scaling up Generative AI across AstraZeneca’s global project portfolio

management over the past year, he has recognized significant tangible wins

beyond financial metrics. Let’s challenge or support this argument as we explore

whether the ROI of GenAI can be demonstrated in multiple ways.